Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine

The objective of this clinical trial is to compare the effectiveness of telemedicine
Cognitive-Behavioral Therapy (CBT) for insomnia [via the American Academy of Sleep Medicine
Sleep Telemedicine (AASM Sleep TM) platform] to gold standard face-to-face CBT for insomnia.
The central hypothesis is that CBT for insomnia delivered by AASM SleepTM will be comparable
to face-to-face CBT for insomnia for clinical outcomes and patient satisfaction, but AASM
SleepTM will be a more cost effective treatment modality (primarily through reduced costs
associated with facility use and patient time). The rationale for the proposed project is
rooted in the critical need to disseminate CBT for insomnia using the most effective and
efficient modalities, with recognition that therapist involvement likely produces the most
favorable outcomes.

Inclusion Criteria:

1. Current diagnosis of insomnia

Exclusion Criteria:

1. Suspicion of or inadequately treated sleep disorder other than insomnia

2. Presence of psychiatric disorders for which CBT for insomnia may be contraindicated

3. Unstable chronic medical condition directly related to insomnia

4. Routine overnight shift work

5. Previous failed adequate trial of CBT for insomnia

6. Unstable dose of sleep medications

7. Lack of access to reliable WiFi connection in the home